This was the second Zika-related summit CDC has hosted in the past year. Though, this one was specific to the vector-control aspect of trying to curtail the spread of Zika and other viruses transmitted by the dangerous, often elusive, Aedes agypti species.
Dr. Kurt Vandock, Head of Public Health for the Bayer U.S. Environmental Science business and a vector biologist, had the privilege of attending both last and this year’s summits. He accepted the award last week on behalf of Bayer, which made financial contributions to both events.
“Bayer is proud to join CDC in combating global health threats like vector-borne diseases,” said Dr. Vandock. “I was honored to accept this award and to sit in on last week’s summit and was very encouraged by the discussion,” he continued. “Bayer is continuing to invest in innovations to help control Aedes aegypti and other dangerous species of mosquito and is passionate about doing our part to help protect public health.”
More facts about the summit and Zika Virus below:
• Bayer this year donated $15,000 to the CDC Foundation in support of Zika research.
• As of February 22, more than 42,000 individuals with lab-confirmed cases of Zika virus have been reported in the United States and its territories, according to the CDC.
• As of February 7, more than 4,600 pregnant women in the United States and its territories have lab evidence of a Zika virus infection, according to the CDC.
To learn more, a CDC Foundation announcement about the summit is here.
(Pictured, from left to right) Dr. Judith Monroe (President and CEO, CDC Foundation), Dr. Kurt Vandock (Head of Public Health for the Bayer U.S. Environmental Science business), and Dr. Patricia Simone (Acting Principal Deputy Director, CDC) Photo credit to Greg Knobloch Photography, LLC.